Cardeas Pharma
Latest round
- Series B
Last raised
- Apr 2015
Total raised
- $46M
Investors
- 5
About Cardeas Pharma
Cardeas Pharma Corp.Cardeas Pharma Corp. specializes in advanced pharmaceutical products aimed at treating complex health issues. The company was founded in Seattle, US, and has undergone significant developments in its strategy.Cardea Pharma specializes in the development and commercialization of advanced pharmaceutical products aimed at addressing critical health challenges. The company's core offerings include a range of innovative therapies designed to enhance patient outcomes across various therapeutic areas. These products are particularly focused on treating chronic conditions and rare diseases, leveraging cutting-edge technologies to improve efficacy and patient adherence. Cardea Pharma’s client base consists of healthcare providers, pharmaceutical distributors, and hospitals across North America and Europe, where they aim to serve both patients and healthcare professionals with high-quality solutions.Cardea Pharma generates revenue through a diversified transaction model that includes both direct-to-consumer sales and partnerships with healthcare institutions. The company's revenue structure is primarily based on the sale of its proprietary pharmaceuticals, which are marketed to hospitals and clinics. Transactions typically involve purchase agreements with healthcare providers that ensure a steady supply of their flagship products. Additionally, partnerships with pharmaceutical wholesalers enhance the distribution network, facilitating broader access to their therapies. The company is focusing on launching innovative therapies designed to address chronic conditions and rare diseases, with anticipated releases within the next few years. Furthermore, Cardeas aims to expand its reach into new geographic markets, specifically targeting Europe and additional regions in North America by 2025, to widen access to its products and increase its client base.
Who invested in Cardeas Pharma
5 investors across 3 rounds
See all investors in Cardeas Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cardeas Pharma
Who invested in Cardeas Pharma?
Cardeas Pharma has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cardeas Pharma raised?
Cardeas Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cardeas Pharma last raise money?
Cardeas Pharma's most recent round on record is a Series B, in Apr 2015.
What does Cardeas Pharma do?
Cardeas Pharma is a pharmaceuticals company.
Where is Cardeas Pharma headquartered?
Cardeas Pharma is headquartered in Seattle, US.
Which VCs invest in companies like Cardeas Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Cardeas Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Cardeas Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.